ATAGI recommends third vax dose for 500,000 patients
And a small group of patients will need three more doses
Half a million severely immunocompromised patients should be getting a third dose of a COVID-19 vaccine, including those on chemotherapy, high-dose corticosteroids, B-cell-depleting therapies and long-term dialysis, ATAGI has recommended.
It’s the first time ATAGI has advised anything beyond a two-dose course, although potential boosters for doctors and other health staff are still under review, with more advice expected to arrive by the end of the month.
“The third dose is intended to maximise
